Windlas Biotech Limited (WINDLAS.BO)
INR 968.85
(0.09%)
INR 968.85
(0.09%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 36.41 Million INR | -27.08% |
| 2022 | 49.93 Million INR | -24.77% |
| 2021 | 66.37 Million INR | -79.48% |
| 2020 | 323.49 Million INR | 11.8% |
| 2019 | 289.34 Million INR | -9.14% |
| 2018 | 318.46 Million INR | -44.55% |
| 2017 | 574.33 Million INR | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2023 Q4 | 36.41 Million INR | 0.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q2 | 63.06 Million INR | 0.0% |
| 2023 FY | 36.41 Million INR | -27.08% |
| 2023 Q3 | - INR | -100.0% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q4 | 49.93 Million INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 FY | 49.93 Million INR | -24.77% |
| 2022 Q2 | 25.08 Million INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 FY | 66.37 Million INR | -79.48% |
| 2021 Q4 | 66.37 Million INR | 0.0% |
| 2021 Q2 | 20.52 Million INR | 0.0% |
| 2021 Q1 | - INR | -100.0% |
| 2020 FY | 323.49 Million INR | 11.8% |
| 2020 Q4 | 323.49 Million INR | 41.03% |
| 2020 Q3 | 229.36 Million INR | 0.0% |
| 2020 Q1 | - INR | -100.0% |
| 2019 Q4 | 284.64 Million INR | 0.0% |
| 2019 FY | 289.34 Million INR | -9.14% |
| 2018 FY | 318.46 Million INR | -44.55% |
| 2017 FY | 574.33 Million INR | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Alkem Laboratories Limited | 14.18 Billion INR | 99.743% |
| Amrutanjan Health Care Limited | 17.28 Million INR | -110.669% |
| Alembic Pharmaceuticals Limited | 5.13 Billion INR | 99.29% |
| AstraZeneca Pharma India Limited | 45.98 Million INR | 20.817% |
| Aurobindo Pharma Limited | 66.47 Billion INR | 99.945% |
| Biofil Chemicals and Pharmaceuticals Limited | 4.38 Million INR | -729.574% |
| Eris Lifesciences Limited | 27.81 Billion INR | 99.869% |
| FDC Limited | 205.18 Million INR | 82.255% |
| Glenmark Life Sciences Limited | 171.48 Million INR | 78.767% |
| Ipca Laboratories Limited | 14.38 Billion INR | 99.747% |
| Jagsonpal Pharmaceuticals Limited | 89.41 Million INR | 59.277% |
| Krebs Biochemicals & Industries Limited | 1.93 Billion INR | 98.118% |
| Laurus Labs Limited | 25.77 Billion INR | 99.859% |
| Lupin Limited | 29.21 Billion INR | 99.875% |
| Medicamen Biotech Limited | 308.17 Million INR | 88.185% |
| Medico Remedies Limited | 80.5 Million INR | 54.772% |
| Megasoft Limited | 1.47 Billion INR | 97.524% |
| NATCO Pharma Limited | 3.71 Billion INR | 99.019% |
| Piramal Pharma Limited | 47.1 Billion INR | 99.923% |
| Sigachi Industries Limited | 1.43 Billion INR | 97.455% |
| Solara Active Pharma Sciences Limited | 10.11 Billion INR | 99.64% |
| Sun Pharmaceutical Industries Limited | 32.73 Billion INR | 99.889% |
| Suven Pharmaceuticals Limited | 649.96 Million INR | 94.398% |
| Syncom Formulations (India) Limited | 724.86 Million INR | 94.977% |
| Themis Medicare Limited | 957.92 Million INR | 96.199% |
| Torrent Pharmaceuticals Limited | 40.22 Billion INR | 99.909% |
| Valiant Laboratories Limited | 767.08 Million INR | 95.253% |
| Wanbury Limited | 1.16 Billion INR | 96.874% |
| ZIM Laboratories Limited | 1.08 Billion INR | 96.654% |
| Zydus Lifesciences Limited | 8.04 Billion INR | 99.547% |
| Ajanta Pharma Limited | 352.8 Million INR | 89.68% |
| Ind-Swift Laboratories Limited | 166.21 Million INR | 78.095% |
| Achyut Healthcare Limited | - INR | -Infinity% |
| Lasa Supergenerics Limited | 220.76 Million INR | 83.507% |
| Sun Pharma Advanced Research Company Limited | 611.5 Million INR | 94.046% |
| Aarti Pharmalabs Limited | 2.85 Billion INR | 98.724% |
| Alpa Laboratories Limited | 52.46 Million INR | 30.601% |
| Gufic Biosciences Limited | 3.32 Billion INR | 98.906% |
| Ind-Swift Limited | 10.13 Billion INR | 99.641% |
| Indoco Remedies Limited | 6.71 Billion INR | 99.458% |
| Hester Biosciences Limited | 2.44 Billion INR | 98.51% |
| Bliss GVS Pharma Limited | 998.4 Million INR | 96.353% |
| Bajaj HealthCare Limited | 3.32 Billion INR | 98.906% |
| RPG Life Sciences Limited | - INR | -Infinity% |
| Mankind Pharma Limited | 2.07 Billion INR | 98.243% |
| Glenmark Pharmaceuticals Limited | 12.3 Billion INR | 99.704% |
| Unichem Laboratories Limited | 2.47 Billion INR | 98.529% |
| Bal Pharma Limited | 1.39 Billion INR | 97.393% |
| Strides Pharma Science Limited | 25.16 Billion INR | 99.855% |
| Venus Remedies Limited | 413.3 Million INR | 91.19% |
| Jubilant Pharmova Limited | 36.64 Billion INR | 99.901% |
| Dr. Reddy's Laboratories Limited | 20.02 Billion INR | 99.818% |
| Divi's Laboratories Limited | 30 Million INR | -21.367% |
| Nectar Lifesciences Limited | 6.35 Billion INR | 99.427% |
| Shilpa Medicare Limited | 9.37 Billion INR | 99.612% |
| Aarti Drugs Limited | 5.64 Billion INR | 99.355% |
| IOL Chemicals and Pharmaceuticals Limited | 327.6 Million INR | 88.886% |
| Suven Life Sciences Limited | 7.09 Million INR | -413.034% |
| J. B. Chemicals & Pharmaceuticals Limited | 3.77 Billion INR | 99.036% |
| Hikal Limited | 8.17 Billion INR | 99.555% |
| Procter & Gamble Health Limited | 95.6 Million INR | 61.914% |
| Sequent Scientific Limited | 4.87 Billion INR | 99.253% |
| Novartis India Limited | 69.7 Million INR | 47.762% |
| Granules India Limited | 13.15 Billion INR | 99.723% |
| Wockhardt Limited | 23.56 Billion INR | 99.845% |
| Brooks Laboratories Limited | 56.41 Million INR | 35.465% |
| Neuland Laboratories Limited | 953.89 Million INR | 96.183% |
| Morepen Laboratories Limited | 289.99 Million INR | 87.444% |
| Kilitch Drugs (India) Limited | 316.46 Million INR | 88.495% |
| Mangalam Drugs & Organics Limited | 984.92 Million INR | 96.303% |